Back to search

Article

Dual transgenesis of T cells with a CD44v6-specific chimeric antigen receptor and a suicide gene for the safe eradication of chemoresistant leukaemia and myeloma

2012-01-01

Abstract excerpt

The recent and extraordinaire clinical successes of T cells modified with chimeric antigen receptors (CAR) against B-cell tumours indicate this strategy as the new frontier for the immunotherapy of haematological malignancies. In this study, we investigated a new CAR-based strategy for the treatment of acute myeloid leukaemia (AML) and multiple myeloma (MM). The ultimate goal of cancer treatment is the elimination...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b97c980e-5882-52a3-a724-c1970eb9cdd5
DOI
10.21954/ou.ro.0000ffd2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dual transgenesis of T cells with a CD44v6-specific chimeric antigen receptor and a suicide gene for the safe eradication of chemoresistant leukaemia and myelomaDOI 10.21954/ou.ro.0000ffd2
Select a neighboring publication to make it the new centre.